Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice

Journal of Leukocyte Biology

Volumn 78, Issue 5, 2005, Pages 1118-1126

  Ikawa, Keiji ^a   Nishioka, Takashi ^a   Yu, Zhiqian ^a   Sugawara, Yumiko ^a   Kawagoe, Junichi ^b   Takizawa, Toshiaki ^b   Primo, Valeria ^c   Nikolic, Boris ^c   Kuroishi, Toshinobu ^a   Sasano, Takashi ^a   Shimauchi, Hidetoshi ^a   Takada, Haruhiko ^a   Endo, Yasuo ^a   Sugawara, Shunji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KOWA COMPANY LTD   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytokine; G protein coupled receptor; Inflammation; PMN; Serine proteases

Indexed keywords

ASKH 95; CLODRONIC ACID; IMMUNOMODULATING AGENT; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; LIPOSOME; LIVER ENZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GR 1; MYELOBLASTIN; NAFAMSTAT MESILATE; PROTEASE ACTIVATED RECEPTOR 2 STIMULATING AGENT; PROTEINASE ACTIVATED RECEPTOR 2; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME BLOOD LEVEL; EPITHELIUM CELL; FEMALE; GENE INDUCTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; LIVER GRANULOMA; LIVER INJURY; LIVER NECROSIS; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RECEPTOR UPREGULATION; TECHNIQUE;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; GUANIDINES; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; MYELOBLASTIN; NEUTROPHIL INFILTRATION; NEUTROPHILS; OLIGOPEPTIDES; PROPIONIBACTERIUM ACNES; RECEPTOR, PAR-2; SERINE ENDOPEPTIDASES;

ANIMALIA; MURINAE; PROPIONIBACTERIUM ACNES;

EID: 27644495337     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0305151     Document Type: Article

References (48)

1. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S., Kurimoto, M. (1995) Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91.
2. Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H. (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423-474.
3. Dinarello, C. A., Fantuzzi, G. (2003) Interleukin-18 and host defense against infection. J. Infect. Dis. 187, S370-S384.
4. Gracie, J. A., Robertson, S. E., McInnes, I. B. (2003) Interleukin-18. J. Leukoc. Biol. 73, 213-224.
5. Hoshino, T., Wiltrout, R. H., Young, H. A. (1999) IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol. 162, 5070-5077.
6. Ossovskaya, V. S., Bunnett, N. W. (2004) Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 84, 579-621.
7. Coughlin, S. R., Camerer, E. (2003) PARticipation in inflammation. J. Clin. Invest. 111, 25-27.
8. O'Brien, P. J., Molino, M., Kahn, M., Brass, L. F. (2001) Protease activated receptors: theme and variations. Oncogene 20, 1570-1581.
9. Nystedt, S., Emilsson, K., Wahlestedt, C., Sundelin, J. (1994) Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA 91, 9208-9212.
10. D'Andrea, M. R., Derian, C. K., Leturcq, D., Baker, S. M., Brunmark, A., Ling, P., Darrow, A. L., Santulli, R. J., Brass, L. F., Andrade-Gordon, P. (1998) Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem. 46, 157-164.
11. Kawabata, A. (2003) Gastrointestinal functions of proteinase-activated receptors. Life Sci. 74, 247-254.
12. Kawagoe, J., Takizawa, T., Matsumoto, J., Tamiya, M., Meek, S. E., Smith, A. J., Hunter, G. D., Plevin, R., Saito, N., Kanke, T., Fujii, M., Wada, Y. (2002) Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn. J. Pharmacol. 88, 77-84.
13. Ferrell, W. R., Lockhart, J. C., Kelso, E. B., Dunning, L., Plevin, R., Meek, S. E., Smith, A. J., Hunter, G. D., McLean, J. S., McGarry, F., Ramage, R., Jiang, L., Kanke, T., Kawagoe, J. (2003) Essential role for proteinase-activated receptor-2 in arthritis. J. Clin. Invest. 111, 35-41.
14. Owen, C. A., Campbell, E. J. (1999) The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65, 137-150.
15. Sugawara, S., Uehara, A., Nochi, T., Yamaguchi, T., Ueda, H., Sugiyama, A., Hanzawa, K., Kumagai, K., Okamura, H., Takada, H. (2001) Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 167, 6568-6575.
16. Uehara, A., Sugawara, S., Muramoto, K., Takada, H. (2002) Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J. Immunol. 169, 4594-4603.
17. Uehara, A., Muramoto, K., Takada, H., Sugawara, S. (2003) Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J. Immunol. 170, 5690-5696.
18. Tsutsui, H., Matsui, K., Kawada, N., Hyodo, Y., Hayashi, N., Okamura, H., Higashino, K., Nakanishi, K. (1997) IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159, 3961-3967.
19. Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda, K., Matsui, K., Kashiwamura, S., Hada, T., Akira, S., Yagita, H., Okamura, H., Nakanishi, K. (1999) Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359-367.
20. Sakao, Y., Takeda, K., Tsutsui, H., Kaisho, T., Nomura, F., Okamura, H., Nakanishi, K., Akira, S. (1999) IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int. Immunol. 11, 471-480.
21. - double negative lymphocytes by bacterial stimulation. Int. Immunol. 2, 775-785.
22. Chen, L., Watanabe, T., Watanabe, H., Sendo, F. (2001) Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur. J. Immunol. 31, 265-275.
23. Van Rooijen, N., Sanders, A. (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93.
24. Van Rooijen, N., Sanders, A. (1996) Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology 23, 1239-1243.
25. Salkowski, C. A., Neta, R., Wynn, T. A., Strassmann, G., van Rooijen, N., Vogel, S. N. (1995) Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J. Immunol. 155, 3168-3179.
26. Endo, Y., Nakamura, M., Nitta, Y., Kumagai, K. (1995) Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumor necrosis factor. Br. J. Pharmacol. 114, 187-193.
27. Geissmann, F., Jung, S., Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
28. +-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol. 74, 1015-1025.
29. Fleming, T. J., Fleming, M. L., Malek, T. R. (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151, 2399-2408.
30. Fujii, S., Hitomi, Y. (1981) New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim. Biophys. Acta 661, 342-345.
31. Ramjee, M. K., Henderson, I. M., McLoughlin, S. B., Padova, A. (2000) The kinetic and structural characterization of the reaction of Nafamostat with bovine pancreatic trypsin. Thromb. Res. 98, 559-569.
32. Issekutz, A. C., Roland, D. M., Patrick, R. A. (1990) The effect of FUT-175 (Nafamstat mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo. Int. J. Immunopharmacol. 12, 1-9.
33. Noguchi, S., Nakatsuka, M., Konishi, H., Kamada, Y., Chekir, C., Kudo, T. (2003) Nafamostat mesilate suppresses NF-κB activation and NO overproduction in LPS-treated macrophages. Int. Immunopharmacol. 3, 1335-1344.
34. Aoyama, T., Ino, Y., Ozeki, M., Oda, M., Sato, T., Koshiyama, Y., Suzuki, S., Fujita, M. (1984) Pharmacological studies of FUT-175, Nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn. J. Pharmacol. 35, 203-227.
35. Doucet, J. J., Hoyt, D. B., Coimbra, R., Schmid-Schonbein, G. W., Junger, W. G., Wolf, P. L., Loomis, W. H., Hugli, T. E. (2004) Inhibition of enteral enzymes by enteroclysis with Nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock. J. Trauma 56, 501-511.
36. Mansell, A., Reinicke, A., Worrall, D. M., O'Neill, L. A. (2001) The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-κB activation by TLR-4. FEBS Lett. 508, 313-317.
37. Kawase, Y., Hoshino, T., Yokota, K., Kuzuhara, A., Kirii, Y., Nishiwaki, E., Maeda, Y., Takeda, J., Okamoto, M., Kato, S., Imaizumi, T., Aizawa, H., Yoshino, K. (2003) Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin. J. Invest. Dermatol. 121, 502-509.
38. 4. J. Immunol. 171, 1009-1015.
39. Tsuji, H., Mukaida, N., Harada, A., Kaneko, S., Matsushita, E., Nakanuma, Y., Tsutsui, H., Okamura, H., Nakanishi, K., Tagawa, Y., Iwakura, Y., Kobayashi, K., Matsushima, K. (1999) Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production. J. Immunol. 162, 1049-1055.
40. + human blood mononuclear cells. J. Clin. Invest. 101, 711-721.
41. Tsutsui, H., Matsui, K., Okamura, H., Nakanishi, K. (2000) Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174, 192-209.
42. Itoi, H., Fujimori, Y., Tsutsui, H., Matsui, K., Futatsugi, S., Okamura, H., Hara, H., Hada, T., Kakishita, E., Nakanishi, K. (2001) Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease. Blood 98, 235-237.
43. Nyvad, B., Kilian, M. (1990) Microflora associated with experimental root surface caries in humans. Infect. Immun. 58, 1628-1633.
44. Jordan, H. V. (1982) Pathogenicity of Actinomyces species. In Host-Parasite Interactions in Periodontal Disease (R. J. Genco, S. E. Mergenhagen, eds.), Washington, DC, American Society for Microbiology, 169-178.
45. Sundqvist, G., Reuterving, C. O. (1980) Isolation of Actinomyces israelii from periapical lesion. J. Endod. 6, 602-606.
46. Smego Jr., R. A., Foglia, G. (1998) Actinomycosis. Clin. Infect. Dis. 26, 1255-1263.
47. Lourbakos, A., Potempa, J., Travis, J., D'Andrea, M. R., Andrade-Gordon, P., Santulli, R., Mackie, E. J., Pike, R. N. (2001) Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect. Immun. 69, 5121-5130.
48. Leung, B. P., Culshaw, S., Gracie, J. A., Hunter, D., Canetti, C. A., Campbell, C., Cunha, F., Liew, F. Y., McInnes, I. B. (2001) A role for IL-18 in neutrophil activation. J. Immunol. 167, 2879-2886.